Summary. In weanling male rats, destruction of the ventromedial hypothalamus causes increased carcass lipid deposition and decreased linear growth without changes in food intake or blood glucose levels. These changes are not dependent on altered pituitary function. Lipogenesis and glucose utilization are increased in vivo and in vitro, while gluconeogenesis is accelerated in vivo. The enhanced lipogenesis occurs before increased gluconeogenesis.
gluconeogenesis This review will deal almost exclusively with the known effects of ventromedial hypothalamic lesions (VMHL) on carbohydrate and lipid metabolism of adipose tissue. It will not discuss changes in pancreatic secretion, hepatic metabolism or feeding behavior except where necessary. Several review articles on experirnental obesity have appeared recently [1, 2, 3, 4, 5, 6] , and the reader interested in a broader discussion of this subject should consult them.
In this review obesity will be defined as an excess of body fat, either absolute or relative to total body weight.
The experimental study of hypothalamic obesity began in 1939 with the work of Hetherington and Ranson [7] . Their data showed 'that mature VMHL rats developed hyperphagia and then obesity. This led quite logically to the hypothesis that VMHL rats had a primary defect in sensing satiety, and that hyperphagia was responsible for the development of adiposity [8] and the more recently noted hyperinsulinaemia [9] .
However, within the past 15 years a large number of studies have demonstrated that this model is not sufficient to explain hypothalamic obesity. In 1965 Han and coworkers [10, 11] observed that weanling VMHL rats developed obesity and impaired linear growth without any increase in food intake. This syndrome was accompanied by decreased physical activity and oxygen consumption, but the decreased activity was not sufficient to explain either the decreased oxygen consumption or the accretion of adipose tissue [12] . Furthermore, although growth hormone deficiency was a concomitant of the syndrome, pituitary dysfunction was neither sufficient nor necessary for the syndrome to develop [13, 14] . Further observations documented direct effects of the hypothalamus on autonomic nervous system function with subsequent changes in insulin secretion and hepatic carbohydrate metabolism [3, 5] . These findings resulted in development of a model of hypothalamic obesity in which hyperinsulinaemia was primary [1, 15] . Based on this model studies on changes in adipose tissue structure and function in VMHL rats began in the late 1960's and have continued to the present.
Body Composition
Mature VMHL rats have increased weight gain due exclusively to the deposition of lipid, and the adipose tissue deposits of these animals are greatly enlarged. This increased adiposity is not dependent on hyperphagia, however, since even restricted or pair-feeding does not prevent increases in adipose tissue [16] . In weanling VMHL rats that are not hyperphagic, similar changes occur [14] . In these latter rats a concomitant diminution in protein accretion occurs [14, 16] as an expression of impaired nitrogen retention and abnormal protein metabolism [17, 18] . The increase in adipose tissue mass is primarily due to adipocyte enlargement rather than proliferation. 
Adipose Tissue Glucose Metabolism
Fat pad segments of obese rats studied in vitro convert more glucose to CO2 and lipids [14] . These findings persist on high fat or fat free diets and are not diminished by 48 h of fasting prior to sacrifice [19] . These changes first become apparent 4 days after lesion placement in ad libitum fed weanling rats. Hypophysectomy and/or growth hormone administration in VMHL rats does not significantly alter the obesity of these rats or the enhanced glucose utilization of their adipose tissue. Insulin responsiveness is normal both in vitro [20] and in vivo (see below). Furthermore, fasting did not reduce insulin sensitivity of fat pads from VMHL rats [21] . Glucose utilization by VMHL rat fat pads rises normally with increasing glucose concentrations in vitro. However, it does not plateau at very high concentrations, whereas tissues from normal rats do exhibit a leveling off of glucose utilization [22] . Glucose incorporation into glycogen is not increased in fat pads of VMHL rats [20] suggesting a stimulation of selective pathways of glucose metabolism and indicating that accelerated glucose transport is not fully responsible for the increased utilization seen in VMHL rat tissues.
Isolated adipocytes studied in collaboration with Dr. Dean Lockwood (Table 2) show increased 2-deoxyglucose transport and glucose utilization as well as normal responses to added insulin [23] . Likewise, insulin resistance is not seen in epididymal fat pad fragments [20] , although slight insulin insensitivity may be present. As a followup to these studies, adipocyte insulin receptors were measured by Dr. Lockwood [23] and found to be normal in terms of numbers of receptors per cell (Table 3) .
Other in vitro studies have demonstrated increased oxidation of both 1-14C glucose and 6J4C glucose in fat pads of weanling VMHL rats. The data indicated that 1-carbon oxidation was preferentially increased [22] . Fructose utilization was also increased, whereas pyruvate metabolism was either normal or decreased [22] . Finally in mature VMHL rats similar enhancement of in vitro glucose metabolism was noted whether such rats were pair-fed with controls or allowed to eat ad libitum [16] .
In vivo studies were next undertaken to provide a more physiological setting in which substrate availability, hormone milieu and innervation are intact. Intravenously injected 14C-glucose disappeared from the blood more rapidly than normal in VMHL rats, and more radioactivity was recovered in tissue lipids of these rats [24] . Following intraperitoneal injection of 14C-glucose, incorporation into tissue lipids was similarly increased in VMHL rats, and responded normally to intraperitoneal insulin administration [25] .
The importance of hyperinsulinaemia in the syndrome remains unclear. We have shown that either pair-feeding [16] or 48 h of fasting [19] eliminates hyperinsulinaemia in weanling VMHL rats but does not decrease the accelerated glucose metabolism by fat pad in vitro. Furthermore, preexisting untreated diabetes does not eliminate all the differences in carcass lipid content or fat pad glucose metabolism usually seen in VMHL rats, although these differences were markedly attenuated [26] . In contrast Bray has shown that hyperinsulinaemia and obesity do not develop in mature female VMHL rats if they have been previously rendered diabetic and then had blood glucose and insulin normalized by islet transplantation [27] . In large female rats with diabetes VMH lesions produce the usual hyperphagia but a somewhat attenuated weight gain [28] . Thus, the question of whether hyperinsulinaemia is essential for the development of obesity in VMHL rats remains unanswered. 
Adipose Tissue Lipid Metabolism
Weanling VMHL rats paradoxically have hypertriglyceridemia in the face of elevated adipose tissue lipoprotein lipase activity which responds normally to heparin. Nonetheless, when incubated with plasma containing ~4C-lipid adipose tissue of VMHL rats took up less radioactivity than normal [29] . Tissues from VMHL rats also released less free fatty acid than normal [30] . Furthermore, glycerol kinase activity was increased in fat pads of VMHL rats [31] . All of these data indicate a decrease in fatty acid uptake and release in the adipose tissue of these rats. Fatty acid synthesis from hexoses is clearly elevated (see above) and fatty acid synthesis as measured by incorporation of tritium from 3H20 is likewise increased both in vivo (Table 4 ) and in vitro (Table 5 ). The in vivo effect is seen within a few hours of lesion production and is apparent in both carcass adipose tissue and liver [32] . Likewise, the enhanced lipogenesis seen in fat pad in vitro is also noted with isolated hepatocytes [33] .
Hypothesis
It is clear that lipogenesis and glucose utilization are increased in VMHL rats, and this phenomenon is independent of hyperphagia or possible pituitary dysfunction. The fact that VMHL rats are normoglycaemic in the face of normal food intake and increased glucose utilization requires an acceleration of gluconeogenesis. Several studies have demonstrated such an acceleration in vivo in a variety of forms of experimental obesity [2, 5, 34, 35, 36, 37] , although studies using perfused liver have not been confirmatory [38] . Perhaps an intact animal preparation is needed either because of neural factors or because of changes in glucose flux which can only be manifest in the whole animal. In vivo iipogenesis accelerates before gluconeogenesis after hypothalamic lesions. Thus, one can postulate that increased glucose utilization creates a transient hypoglycaemia which is only subsequently reversed by a compensatory increase in gluconeogenesis. Additional support has recently been obtained in our laboratory by MacKenzie and Luboshitzky. They noted that accelerated gluconeogenesis was seen in rats with hyperphagia and obesity induced by hypothalamic knife cuts, and it became much more apparent when the obese rats were limited to normal food intake (Table 6) [39].
The only source for increased glucose production is amino acids. The constant diversion of these into gluconeogenic pathways might well explain the diminished growth and carcass protein content of VMHL rats and the negative nitrogen balance exhibited by these rats.
Thus, finally, one can construct a model of VMHL obesity in which hyperinsulinaemia, increased glucose utilization and increased lipogenesis occur very early. The enhanced glucose disappearance creates a need for extra glucose which is met either by increased food intake or by diversion of amino acid carbon into carbohydrate. Finally, this diversion leads to deficiencies in growth and carcas.s protein content. 
Discussion after Goldman's Presentation
Nicolaidis: The rats you describe with VMHL and hyperinsulinaemia do not seem to resemble the syndrome seen in people with insulinomas. These people are often lean and have hypoglycaemia. Why are they not obese?
Goldman: Actually, I believe most people with insulinomas are actually obese. But I agree with you in that there must be other factors at work in the VMHL obesity than just hyperinsulinaemia. I actually feel that the liver of these animals is going to be insulin resistant in many pathways. Perhaps some of the work of Dr. Shimazu will be very important in the explanation, although I'm not sure that the stimulation studies will provide the entire explanation.
